First Manhattan’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,000
| Closed | -$218K | – | 1578 |
|
|
2023
Q1 | $218K | Hold |
25,000
| – | – | ﹤0.01% | 664 |
|
|
2022
Q4 | $157K | Hold |
25,000
| – | – | ﹤0.01% | 743 |
|
|
2022
Q3 | $87K | Hold |
25,000
| – | – | ﹤0.01% | 843 |
|
|
2022
Q2 | $73K | Hold |
25,000
| – | – | ﹤0.01% | 903 |
|
|
2022
Q1 | $77K | Hold |
25,000
| – | – | ﹤0.01% | 928 |
|
|
2021
Q4 | $84K | Hold |
25,000
| – | – | ﹤0.01% | 899 |
|
|
2021
Q3 | $91K | Hold |
25,000
| – | – | ﹤0.01% | 880 |
|
|
2021
Q2 | $109K | Hold |
25,000
| – | – | ﹤0.01% | 846 |
|
|
2021
Q1 | $113K | Hold |
25,000
| – | – | ﹤0.01% | 808 |
|
|
2020
Q4 | $143K | Hold |
25,000
| – | – | ﹤0.01% | 729 |
|
|
2020
Q3 | $181K | Buy |
25,000
+22,500
| +900% | +$163K | ﹤0.01% | 669 |
|
|
2020
Q2 | $8K | Buy |
+2,500
| New | +$8K | ﹤0.01% | 1200 |
|